Thank you for visiting the Cook MyoSite Virtual Exhibit!

Formed in 2002, Cook MyoSite is dedicated to the development and subsequent commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of a variety of disorders. 

Autologous muscle derived cells (AMDC) is a cell therapy being clinically investigated by Cook MyoSite for female stress urinary incontinence, fecal incontinence, underactive bladder, and tongue dysphagia across more than 600 subjects.